483Jan 27, 2017
483 Document: GlaxoSmithKline Biologicals SA


On Jan 27, 2017, the FDA inspected GlaxoSmithKline Biologicals SA's Rixensart site. Explore the inspectional observations.


On Jan 27, 2017, the FDA inspected GlaxoSmithKline Biologicals SA's Rixensart site. Explore the inspectional observations.